July 15 (Reuters) - Genetic Technologies Ltd (GTG) :
- GENETIC TECHNOLOGIES PROVIDES UPDATE ON COVID-19 DISEASE SEVERITY TEST
- GENETIC TECHNOLOGIES LTD - FILED A PROVISIONAL PATENT FOR ITS COVID-19 SEVERITY RISK TEST WITH PATENT OFFICE IN AUSTRALIA
- GENETIC TECHNOLOGIES - IN DISCUSSIONS WITH INTERNATIONAL BIOBANKS AND CLINICAL LABORATORIES TO SOURCE AN INDEPENDENT CROSS-VALIDATION DATASET
- GENETIC TECHNOLOGIES LTD - OPTIONS FOR CLINICAL RISK MODEL CURRENTLY BEING EVALUATED
- GENETIC TECHNOLOGIES LTD - COMMENCED ORDERING ITS FIRST SNP ARRAY PANEL FROM US-BASED THERMO FISHER SCIENTIFIC
- GENETIC TECHNOLOGIES LTD - CONFIRMED CAPACITY TO SCALE UP PRODUCTION FOR GLOBAL-ROLL OUT OF COVID-19 SEVERITY RISK TEST WITH MAJOR MANUFACTURERS
News: GTG Genetic Technologies Files Provisional Patent For Its COVID-19 Severity Risk Test With...
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
